- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x GLY: GLYCINE(Non-covalent)
GLY.6: 7 residues within 4Å:- Chain A: F.192, Y.235, T.237, F.240
- Chain B: F.96, R.98, S.162
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:F.192, A:T.237, B:S.162
- Salt bridges: B:R.98
GLY.16: 7 residues within 4Å:- Chain A: F.96, R.98, S.162
- Chain E: F.192, Y.235, T.237, F.240
4 PLIP interactions:2 interactions with chain E, 2 interactions with chain A- Hydrogen bonds: E:F.192, E:T.237, A:S.162
- Salt bridges: A:R.98
GLY.17: 7 residues within 4Å:- Chain B: F.192, Y.235, T.237, F.240
- Chain C: F.96, R.98, S.162
4 PLIP interactions:2 interactions with chain C, 2 interactions with chain B- Hydrogen bonds: C:S.162, B:F.192, B:T.237
- Salt bridges: C:R.98
GLY.27: 7 residues within 4Å:- Chain C: F.192, Y.235, T.237, F.240
- Chain D: F.96, R.98, S.162
4 PLIP interactions:2 interactions with chain D, 2 interactions with chain C- Hydrogen bonds: D:S.162, C:F.192, C:T.237
- Salt bridges: D:R.98
GLY.37: 7 residues within 4Å:- Chain D: F.192, Y.235, T.237, F.240
- Chain E: F.96, R.98, S.162
4 PLIP interactions:2 interactions with chain E, 2 interactions with chain D- Hydrogen bonds: E:S.162, D:F.192, D:T.237
- Salt bridges: E:R.98
- 25 x PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate(Non-functional Binders)(Non-covalent)
PIO.7: 1 residues within 4Å:- Ligands: PIO.9
No protein-ligand interaction detected (PLIP)PIO.8: 1 residues within 4Å:- Ligands: PIO.50
No protein-ligand interaction detected (PLIP)PIO.9: 2 residues within 4Å:- Chain A: W.448
- Ligands: PIO.7
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:K.452
PIO.10: 2 residues within 4Å:- Chain A: W.276
- Ligands: PX4.11
No protein-ligand interaction detected (PLIP)PIO.15: 4 residues within 4Å:- Chain A: S.311, V.313
- Chain B: I.258
- Ligands: PIO.19
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:V.313, B:I.258
PIO.18: 1 residues within 4Å:- Ligands: PIO.20
No protein-ligand interaction detected (PLIP)PIO.19: 1 residues within 4Å:- Ligands: PIO.15
No protein-ligand interaction detected (PLIP)PIO.20: 2 residues within 4Å:- Chain B: W.448
- Ligands: PIO.18
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:K.452
PIO.21: 2 residues within 4Å:- Chain B: W.276
- Ligands: PX4.22
No protein-ligand interaction detected (PLIP)PIO.26: 4 residues within 4Å:- Chain B: S.311, V.313
- Chain C: I.258
- Ligands: PIO.29
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain C- Hydrophobic interactions: B:V.313, C:I.258
PIO.28: 1 residues within 4Å:- Ligands: PIO.30
No protein-ligand interaction detected (PLIP)PIO.29: 1 residues within 4Å:- Ligands: PIO.26
No protein-ligand interaction detected (PLIP)PIO.30: 2 residues within 4Å:- Chain C: W.448
- Ligands: PIO.28
1 PLIP interactions:1 interactions with chain C- Salt bridges: C:K.452
PIO.31: 2 residues within 4Å:- Chain C: W.276
- Ligands: PX4.32
No protein-ligand interaction detected (PLIP)PIO.36: 4 residues within 4Å:- Chain C: S.311, V.313
- Chain D: I.258
- Ligands: PIO.39
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:I.258, C:V.313
PIO.38: 1 residues within 4Å:- Ligands: PIO.40
No protein-ligand interaction detected (PLIP)PIO.39: 1 residues within 4Å:- Ligands: PIO.36
No protein-ligand interaction detected (PLIP)PIO.40: 2 residues within 4Å:- Chain D: W.448
- Ligands: PIO.38
1 PLIP interactions:1 interactions with chain D- Salt bridges: D:K.452
PIO.41: 2 residues within 4Å:- Chain D: W.276
- Ligands: PX4.42
No protein-ligand interaction detected (PLIP)PIO.46: 4 residues within 4Å:- Chain D: S.311, V.313
- Chain E: I.258
- Ligands: PIO.52
2 PLIP interactions:1 interactions with chain E, 1 interactions with chain D- Hydrophobic interactions: E:I.258, D:V.313
PIO.50: 4 residues within 4Å:- Chain A: I.258
- Chain E: S.311, V.313
- Ligands: PIO.8
2 PLIP interactions:1 interactions with chain E, 1 interactions with chain A- Hydrophobic interactions: E:V.313, A:I.258
PIO.51: 1 residues within 4Å:- Ligands: PIO.53
No protein-ligand interaction detected (PLIP)PIO.52: 1 residues within 4Å:- Ligands: PIO.46
No protein-ligand interaction detected (PLIP)PIO.53: 2 residues within 4Å:- Chain E: W.448
- Ligands: PIO.51
1 PLIP interactions:1 interactions with chain E- Salt bridges: E:K.452
PIO.54: 2 residues within 4Å:- Chain E: W.276
- Ligands: PX4.55
No protein-ligand interaction detected (PLIP)- 20 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PX4.11: 5 residues within 4Å:- Chain A: V.273, W.276
- Chain E: F.339
- Ligands: PIO.10, PX4.47
Ligand excluded by PLIPPX4.12: 3 residues within 4Å:- Chain A: L.325, I.428
- Ligands: PX4.22
Ligand excluded by PLIPPX4.13: 2 residues within 4Å:- Chain A: I.431, C.435
Ligand excluded by PLIPPX4.14: 4 residues within 4Å:- Chain A: I.318, I.442, I.450, Y.451
Ligand excluded by PLIPPX4.22: 5 residues within 4Å:- Chain A: F.339
- Chain B: V.273, W.276
- Ligands: PX4.12, PIO.21
Ligand excluded by PLIPPX4.23: 3 residues within 4Å:- Chain B: L.325, I.428
- Ligands: PX4.32
Ligand excluded by PLIPPX4.24: 2 residues within 4Å:- Chain B: I.431, C.435
Ligand excluded by PLIPPX4.25: 4 residues within 4Å:- Chain B: I.318, I.442, I.450, Y.451
Ligand excluded by PLIPPX4.32: 5 residues within 4Å:- Chain B: F.339
- Chain C: V.273, W.276
- Ligands: PX4.23, PIO.31
Ligand excluded by PLIPPX4.33: 3 residues within 4Å:- Chain C: L.325, I.428
- Ligands: PX4.42
Ligand excluded by PLIPPX4.34: 2 residues within 4Å:- Chain C: I.431, C.435
Ligand excluded by PLIPPX4.35: 4 residues within 4Å:- Chain C: I.318, I.442, I.450, Y.451
Ligand excluded by PLIPPX4.42: 5 residues within 4Å:- Chain C: F.339
- Chain D: V.273, W.276
- Ligands: PX4.33, PIO.41
Ligand excluded by PLIPPX4.43: 3 residues within 4Å:- Chain D: L.325, I.428
- Ligands: PX4.55
Ligand excluded by PLIPPX4.44: 2 residues within 4Å:- Chain D: I.431, C.435
Ligand excluded by PLIPPX4.45: 4 residues within 4Å:- Chain D: I.318, I.442, I.450, Y.451
Ligand excluded by PLIPPX4.47: 3 residues within 4Å:- Chain E: L.325, I.428
- Ligands: PX4.11
Ligand excluded by PLIPPX4.48: 2 residues within 4Å:- Chain E: I.431, C.435
Ligand excluded by PLIPPX4.49: 4 residues within 4Å:- Chain E: I.318, I.442, I.450, Y.451
Ligand excluded by PLIPPX4.55: 5 residues within 4Å:- Chain D: F.339
- Chain E: V.273, W.276
- Ligands: PX4.43, PIO.54
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kindig, K. et al., Physiological modulation of alpha3 glycine receptors. To Be Published
- Release Date
- 2024-11-13
- Peptides
- Glycine receptor subunit alpha-3: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x GLY: GLYCINE(Non-covalent)
- 25 x PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate(Non-functional Binders)(Non-covalent)
- 20 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kindig, K. et al., Physiological modulation of alpha3 glycine receptors. To Be Published
- Release Date
- 2024-11-13
- Peptides
- Glycine receptor subunit alpha-3: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.